You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

PrEPLoveLife launched to increase awareness of HIV preventative meds

By Dermot - 15th Feb 2018 | 2 views

According to new research by Gay Community News, 57 per cent of people taking PrEP are getting it from unregulated sources, particularly online providers.

The research undertaken by <em>Gay Community News</em>, on behalf of Teva Pharmaceuticals Ireland, examined a number of areas in relation to PrEP such as; sexual health, sexually transmitted infections (STIs), attitudes on HIV and awareness and use of PrEP amongst the gay community. There were 622 respondents to the survey, of which 97 per cent were male. Teva is a provider of generic PrEP medication.

The research informs a new campaign entitled PrEPLoveLife. This campaign is designed to increase awareness of PrEP amongst groups most at risk of HIV infection and transmission while also informing the general public “on the overall positive effect PrEP has for modern day Ireland, in conjunction with safer sex practices”, according to a press release.

While the research findings show high levels of awareness of PrEP generally, 30 per cent of respondents did not know or were unsure whether it was available in Ireland.

One third of 24-to 30-year olds (33 per cent) – a key target group for HIV risk reduction strategies – were not aware or were unsure that PrEP was available in Ireland; only 10 per cent of respondents are currently using PrEP, with 81 per cent taking it on a daily basis; and of those using PrEP, a majority (57 per cent) said they obtain PrEP from unregulated sources, with the majority doing so online. The next largest sources were pharmacy (18 per cent), an STI clinic (15 per cent) or from a hospital (6 per cent).

On STI testing, the survey found that just 18 per cent of respondents has an STI test at least every three months, 24 per cent do so every six months, 38 per cent at least once a year, but 19 per cent rarely or ever do.

Some 65 per cent of those surveyed said that HIV is a topic of conversation amongst their peers, while almost three-in-five (58 per cent) said they would tell a new partner their HIV status before having sex with that partner.

Also, 55 per cent of those surveyed bring condoms with them on a date, while 43 per cent of respondents would not expect their date to bring condoms.

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]